101 related articles for article (PubMed ID: 12942118)
1. Functional analysis of the actin-binding protein, tropomyosin 1, in neuroblastoma.
Yager ML; Hughes JA; Lovicu FJ; Gunning PW; Weinberger RP; O'Neill GM
Br J Cancer; 2003 Sep; 89(5):860-3. PubMed ID: 12942118
[TBL] [Abstract][Full Text] [Related]
2. Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.
Shah V; Bharadwaj S; Kaibuchi K; Prasad GL
Oncogene; 2001 Apr; 20(17):2112-21. PubMed ID: 11360195
[TBL] [Abstract][Full Text] [Related]
3. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors.
Raval GN; Bharadwaj S; Levine EA; Willingham MC; Geary RL; Kute T; Prasad GL
Oncogene; 2003 Sep; 22(40):6194-203. PubMed ID: 13679858
[TBL] [Abstract][Full Text] [Related]
4. Immunofluorescent detection of actin cytoskeleton in spontaneously transformed and B77-supertransformed cells using antibody to tropomyosin.
Urbancíková M; Grófová M
Neoplasma; 1990; 37(6):703-10. PubMed ID: 2177151
[TBL] [Abstract][Full Text] [Related]
5. N terminus is essential for tropomyosin functions: N-terminal modification disrupts stress fiber organization and abolishes anti-oncogenic effects of tropomyosin-1.
Bharadwaj S; Hitchcock-DeGregori S; Thorburn A; Prasad GL
J Biol Chem; 2004 Apr; 279(14):14039-48. PubMed ID: 14722123
[TBL] [Abstract][Full Text] [Related]
6. Tropomodulin and tropomyosin mediate lens cell actin cytoskeleton reorganization in vitro.
Fischer RS; Lee A; Fowler VM
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):166-74. PubMed ID: 10634617
[TBL] [Abstract][Full Text] [Related]
7. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia alters the recruitment of tropomyosins into the actin stress fibres of neuroblastoma cells.
Glass JJ; Phillips PA; Gunning PW; Stehn JR
BMC Cancer; 2015 Oct; 15():712. PubMed ID: 26475688
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
[TBL] [Abstract][Full Text] [Related]
10. Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma.
Lasorella A; Boldrini R; Dominici C; Donfrancesco A; Yokota Y; Inserra A; Iavarone A
Cancer Res; 2002 Jan; 62(1):301-6. PubMed ID: 11782392
[TBL] [Abstract][Full Text] [Related]
11. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
Lutz W; Schwab M
Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
[TBL] [Abstract][Full Text] [Related]
12. Suppression of src-induced transformed phenotype by expression of tropomyosin-1.
Prasad GL; Masuelli L; Raj MH; Harindranath N
Oncogene; 1999 Mar; 18(11):2027-31. PubMed ID: 10208425
[TBL] [Abstract][Full Text] [Related]
13. Suppression of neoplastic transformation and regulation of cytoskeleton by tropomyosins.
Shah V; Braverman R; Prasad GL
Somat Cell Mol Genet; 1998 Sep; 24(5):273-80. PubMed ID: 10696235
[TBL] [Abstract][Full Text] [Related]
14. Anti-tropomyosin antibodies co-localise with actin microfilaments and label plasmodesmata.
Faulkner CR; Blackman LM; Collings DA; Cordwell SJ; Overall RL
Eur J Cell Biol; 2009 Jun; 88(6):357-69. PubMed ID: 19328591
[TBL] [Abstract][Full Text] [Related]
15. Disordered metabolism of microfilament proteins, tropomyosin and actin, in mouse mammary epithelial cells expressing the Ha-ras oncogene.
Bhattacharya B; Ciardiello F; Salomon DS; Cooper HL
Oncogene Res; 1988; 3(1):51-65. PubMed ID: 3060798
[TBL] [Abstract][Full Text] [Related]
16. [Effects of antisense N-myc gene on nerve growth factor-induced differentiation of neuroblastoma cell line].
Chen J; Liu T; Zhe X; Jiang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Jun; 21(3):197-202. PubMed ID: 12569653
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the expression of tropomyosins and actin cytoskeleton by ras transformation.
Prasad GL
Methods Enzymol; 2006; 407():410-22. PubMed ID: 16757342
[TBL] [Abstract][Full Text] [Related]
18. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
Raschella G; Romeo A; Negroni A; Pucci S; Dominici C; Castello MA; Bevilacqua P; Felsani A; Calabretta B
Cancer Res; 1994 Apr; 54(8):2251-5. PubMed ID: 8174135
[TBL] [Abstract][Full Text] [Related]
19. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
[TBL] [Abstract][Full Text] [Related]
20. Probing cytoskeleton organisation of neuroblastoma cells with single-cell force spectroscopy.
Mescola A; Vella S; Scotto M; Gavazzo P; Canale C; Diaspro A; Pagano A; Vassalli M
J Mol Recognit; 2012 May; 25(5):270-7. PubMed ID: 22528188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
